Recent News

• 08.05.2026 - Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
• 05.19.2026 - Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
• 05.13.2026 - Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
• 05.06.2026 - Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
• 04.21.2026 - Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
• 03.25.2026 - Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
• 03.18.2026 - Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
• 12.10.2025 - Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
• 11.12.2025 - Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
• 11.05.2025 - Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Recent Filings

• 07.31.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2026 - 4 Statement of changes in beneficial ownership of securities